about
Sex-associated hormones and immunity to protozoan parasites.Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis.Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy.Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune systemCorrelation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer.Immunological factors in pregnancy wastage: fact or fiction.Clinical implication of natural killer cells and reproduction.Correlation between serum zinc levels and successful immunotherapy in recurrent spontaneous abortion patients.Decidual CD56+ Natural Killer Cells in Spontaneous Early Pregnancy Loss- An Immunohistochemical Study.Immunological modes of pregnancy loss.Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review.Does immunotherapy for treatment of reproductive failure enhance live births?A blessing and a curse: is high NK cell activity good for health and bad for reproduction?TJ6: the pregnancy-associated cytokine.Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials.Assisted reproductive technologies and immune infertility.Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience.A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss.Intravenous immunoglobulin for repeated IVF failure and unexplained infertility.Impact of age on reproductive outcome in women with recurrent spontaneous abortions and infertility of immune etiology.Endometrial CD16(+) and CD16(-) NK cell count in fertility and unexplained infertility.The effect of valacyclovir treatment on natural killer cells of infertile women.Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss.Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure.Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.Etiological evaluation of repeated biochemical pregnancy in infertile couples who have undergone in vitro fertilization.NK cell abnormality and its treatment in women with reproductive failures such as recurrent pregnancy loss, implantation failures, preeclampsia, and pelvic endometriosis.Increasing circulating T-cell activation markers are linked to subsequent implantation failure after transfer of in vitro fertilized embryos.Suppression of natural killer cell activity and interleukin-2 concentration of serum obtained from in vitro fertilization-embryo transfer patients.Reciprocal alteration in circulating TJ6+ CD19+ and TJ6+ CD56+ leukocytes in early pregnancy predicts success or miscarriage.Expression of natural cytotoxicity receptors and cytokine production on endometrial natural killer cells in women with recurrent pregnancy loss or implantation failure, and the expression of natural cytotoxicity receptors on peripheral blood naturalImmunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase.Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF.Up-regulation of natural killer cell cytotoxicity by interleukin-2: the effect of sex and parity.
P2860
Q33975709-AAE05B26-C949-47D2-BB3D-D5751D3A25B8Q34388536-DA92742C-18A4-4CC6-A42A-F414D3202B49Q34583580-B42E45A2-7303-4D42-8268-E221A91A8801Q35233081-EC78EF78-D4A7-41E9-A0C8-41F40D3E1FDFQ36271825-7D333CF4-A962-4FA7-9490-D3D2975F321EQ37108648-61F50776-E4A4-4E71-AFC8-4DFB66825765Q37135758-5964B9C4-3084-4C37-BB95-E8BFF6BD0814Q37186629-02690C16-CCA1-4437-AAD5-02F4EEC3AA6EQ37435415-F3375529-4DD9-4ED5-8523-547AFAFC1EE4Q37724415-3A3B0976-1E49-4122-8B14-227FFF696361Q37879826-9CBA7526-1D71-4D48-84D5-5E60A0C71D35Q37984847-BAE44F96-4DF8-460B-9048-1290EF6EB76EQ38962831-EE4C2364-2F2E-4D5D-987C-D21B1A275277Q41062882-737F39E0-0015-45E7-B55F-E7F296FF062EQ41062890-6FF287EC-8DC5-4DE5-A751-7A21B5DB13A2Q41266997-A2800E68-75B3-40DC-A689-BF71BD1088E0Q41722639-679F559A-1F03-4B31-A44E-097352FFA165Q43287048-962D9623-DF18-4DC3-9676-B75F96FA251AQ43736662-4839CE14-4A2C-4957-9940-6CE4A783AE50Q43883392-229C911A-F50B-4725-8D8E-97BE9883D92CQ44249655-FE044B99-4FA5-4392-96DA-230F3A9A4727Q44946118-E7787B7A-D91A-4B3D-9711-F9A3B8F166E4Q46195755-BBBB0495-845E-4E8B-A177-B361F39DCC50Q46350031-91EC654E-D60A-4141-B315-8B3E9882F74DQ46620083-00C5111E-BCEA-4B2A-B1A3-FB76E921D09EQ47117797-1556DDFC-6F80-4A0C-9880-F88B9EC3FECBQ47145348-1D795F71-91AF-495A-AD2E-39E8420944CFQ47323980-9F5D5C3A-ACF5-4CF5-B217-70992B2D084CQ47744621-7DE2A6B0-188B-4D18-8024-F7234085EFF0Q47871299-98C98545-519A-404E-AAEA-B9B8E4A5FEA4Q48225500-D95EBDB0-35AE-48E3-B984-EC22C0584904Q51963660-20FB52E2-7F56-409B-9254-7AA1B834E02FQ53244337-2CE05885-B2C7-4B3C-9D67-26F7D5B6A89EQ54529498-7BBC232D-2A10-47C3-9624-496334B8390F
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Systemic CD56+ cells can predict pregnancy outcome.
@en
Systemic CD56+ cells can predict pregnancy outcome.
@nl
type
label
Systemic CD56+ cells can predict pregnancy outcome.
@en
Systemic CD56+ cells can predict pregnancy outcome.
@nl
prefLabel
Systemic CD56+ cells can predict pregnancy outcome.
@en
Systemic CD56+ cells can predict pregnancy outcome.
@nl
P2093
P2860
P1476
Systemic CD56+ cells can predict pregnancy outcome.
@en
P2093
P2860
P356
10.1111/J.1600-0897.1995.TB01136.X
P577
1995-01-01T00:00:00Z